Early treatment with aspirin plus extended-release dipyridamole for transient ischaemic attack or ischaemic stroke within 24 h of symptom onset (EARLY trial): a randomised, open-label, blinded-endpoint trial

The Lancet Neurology

Volumn 9, Issue 2, 2010, Pages 159-166

  Dengler, Reinhard ^a   Diener, Hans Christoph ^b   Schwartz, Andreas ^c   Grond, Martin ^d   Schumacher, Helmut ^e   Machnig, Thomas ^e   Eschenfelder, Christoph Cyrill ^e,f   Leonard, Joachim ^e   Weissenborn, Karin ^a   Kastrup, Andreas ^g   Haberl, Roman ^h  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

^c Klinikum Hannover   (Germany)

^d Kreisklinikum Siegen ^*  (Germany)

^e BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

^f UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^g UNIVERSITY OF GÖTTINGEN   (Germany)

^h Munich Municipal Hospital   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ACETYLSALICYLIC ACID PLUS DIPYRIDAMOLE;

ABDOMINAL PAIN; ADULT; AGED; ARTICLE; BLEEDING; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; DIARRHEA; DISABILITY; DIZZINESS; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; EARLY INTERVENTION; FEMALE; GERMANY; HEADACHE; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MORTALITY; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NAUSEA; NEUROLOGIC DISEASE; OPEN STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RANKIN SCALE; SINGLE BLIND PROCEDURE; STROKE UNIT; SYMPTOM; TELEPHONE; TRANSIENT ISCHEMIC ATTACK; TREATMENT DURATION; VOMITING;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ASPIRIN; DIPYRIDAMOLE; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; FEMALE; GERMANY; HUMANS; ISCHEMIC ATTACK, TRANSIENT; LOGISTIC MODELS; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 76549092810     PISSN: 14744422     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1474-4422(09)70361-8     Document Type: Article

References (22)

1. Adams R.J., Albers G., Alberts M.J., et al. Update to the AHA/aspirin recommendations for the prevention of stroke in patients with stroke and transient ischemic attack. Stroke 39 (2008) 1647-1652
2. Albers G.W., Amarenco P., Easton D., Sacco R.L., Teal P., and American College of Chest Physicians. Antithrombotic and thrombolytic therapy for ischemic stroke: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition). Chest 133 6 Suppl 1 (2008) 630S-669S
3. European Stroke Organisation (ESO); Executive Committee and the ESO Writing Committee. Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovasc Dis 25 (2008) 457-507
4. Diener H.C., Cunha L., Forbes C., Sivenius J., Smets P., and Lowenthal A. European stroke prevention study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci 143 (1996) 1-3
5. ESPRIT Study Group, Halkes P.H., van Gijn J., Kappelle L.J., Koudstaal P.J., and Algra A. Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemic of arterial origin (ESPRIT): randomised controlled trial. Lancet 367 (2006) 1665-1673
6. CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 348 (1996) 1329-1339
7. Sacco R., Diener H.-C., Yusuf S., et al. Aspirin and extended-release dipyridamole versus clopidogrel for recurrent strokes. N Engl J Med 359 (2008) 1238-1251
8. CAST (Chinese Acute Stroke Trial) Collaborative Group. CAST: randomised placebo-controlled trial of early aspirin use in 20 000 patients with acute ischaemic stroke. Lancet 349 (1997) 1641-1649
9. International Stroke Trial Collaborative Group. The international stroke trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19 435 patients with acute ischaemic stroke. Lancet 349 (1997) 1569-1581
10. Kennedy J., Hill M.D., Ryckborst K.J., Eliasziw M., Demchuk A.M., Buchan A.M., and FASTER investigators. Fast assessment of stroke and transient ischaemic attack to prevent early recurrence (FASTER): a randomised controlled pilot trial. Lancet Neurol 6 (2007) 961-969
11. Zaidi SF, Syed T, Salgado, E. Combination aspirin/dipyridamole therapy given at onset of acute cerebroevent improves short-term clinical outcome. 131st annual meeting of the American Neurological Association (ANA); Chicago, IL, USA; 8-11 Oct, 2006. T-76 (abstr).
12. Declaration of Helsinki. Ethical principles for medical research involving human subjects. Amended by the 48th World Medical Association General assembly; Somerset West, Republic of South Africa (October 1996). http://www.wma.net/en/30publications/10policies/b3/index.html (accessed December, 2009).
13. Guideline for good clinical practice E6(R1). International conference on harmonisation harmonised tripartite guideline (1996). http://www.ich.org/LOB/media/MEDIA482.pdf (accessed September, 2009).
14. Serebruany V.L., Malinin A.L., and Sane D.C. Rapid platelet inhibition after a single capsule of Aggrenox: challenging a conventional full-dose aspirin antiplatelet advantage?. Am J Hematol 72 (2003) 280-281
15. Audebert H.J., Schenkel J., Heuschmann P.U., Bogdahn U., Haberl R.L., and Telemedic pilot project for integrative stroke care group. Effects of the implementation of a telemedical stroke network: the telemedic pilot project for integrative stroke care (TEMPiS) in Bavaria, Germany. Lancet Neurol 5 (2006) 742-748
16. The National Institute of Neurological Disorders and Stroke rt-PA stroke study group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 333 (1995) 1581-1587
17. Schrader J., Lüders S., Kulschewski A., et al. The ACCESS study: evaluation of acute candesartan cilexetil therapy in stroke survivors. Stroke 34 (2003) 1699-1703
18. Potter J.F., Robinson T.G., Ford G.A., et al. Controlling hypertension and hypotension immediately post-stroke (CHHIPS): a randomised, placebo-controlled, double-blind pilot trial. Lancet Neurol 8 (2009) 48-56
19. Rothwell P.M., Giles M.F., Chandratheva A., et al. Effect of urgent treatment of transient ischaemic attack and minor stroke on early recurrent stroke (EXPRESS study): a prospective population-based sequential comparison. Lancet 370 (2007) 1432-1442
20. Lavallée P.C., Meseguer E., Abboud H., et al. A transient ischaemic attack clinic with round-the-clock access (SOS-TIA): feasibility and effects. Lancet Neurol 6 (2007) 953-960
21. Diener H.C., Bogousslavsky J., Brass L.M., et al. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised double-blind, placebo-controlled trial. Lancet 364 (2004) 331-337
22. EMEA. Annex 1: summary of product characteristics. http://www.emea.europa.eu/humandocs/PDFs/EPAR/Plavix/emea-combined-h174e n.pdf (accessed November, 2009).